Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Moses

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
American Family Physician|December 21, 2004
Insulin therapy componentsAlan Moses
BMJ (Clinical Research Ed.)|July 12, 2013
Novo Nordisk replies to BMJ investigation on incretins and pancreatic damageAlan Moses
BMJ (Clinical Research Ed.)|June 5, 2012
Novo Nordisk's reply to call for withdrawal of liraglutideAlan Moses
Postgraduate Medicine|October 26, 2012
Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pensDavid Oyer, Marcus Niemeyer, Alan Moses
Journal of Diabetes Science and Technology|June 29, 2018
Concentrations of Intact Insulin Concurs With FDA and EMA Standards When Measured by HPLC in Different Parts of the Distribution Cold ChainAlan Moses, Jesper Bjerrum, Morten Hach, et al.
Endocrine|March 11, 2005
Prandial glucose regulation in the glucose triad: emerging evidence and insightsPaul Beisswenger, Robert J Heine, Lawrence A Leiter, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemiaWaleed Aldhahi, Jen Armstrong, Clara Bouche, et al.
Archives of Internal Medicine|October 27, 2004
Postprandial glucose regulation and diabetic complicationsAntonio Ceriello, Markolf Hanefeld, Lawrence Leiter, et al.
G3 (Bethesda, Md.)|June 7, 2015
CYCLoPs: A Comprehensive Database Constructed from Automated Analysis of Protein Abundance and Subcellular Localization Patterns in Saccharomyces cerevisiaeJudice L Y Koh, Yolanda T Chong, Helena Friesen, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trialsBernard Zinman, J Hans DeVries, Bruce Bode, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
American Family Physician|December 21, 2004
Insulin therapy componentsAlan Moses
BMJ (Clinical Research Ed.)|July 12, 2013
Novo Nordisk replies to BMJ investigation on incretins and pancreatic damageAlan Moses
BMJ (Clinical Research Ed.)|June 5, 2012
Novo Nordisk's reply to call for withdrawal of liraglutideAlan Moses
Postgraduate Medicine|October 26, 2012
Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pensDavid Oyer, Marcus Niemeyer, Alan Moses
Journal of Diabetes Science and Technology|June 29, 2018
Concentrations of Intact Insulin Concurs With FDA and EMA Standards When Measured by HPLC in Different Parts of the Distribution Cold ChainAlan Moses, Jesper Bjerrum, Morten Hach, et al.
Endocrine|March 11, 2005
Prandial glucose regulation in the glucose triad: emerging evidence and insightsPaul Beisswenger, Robert J Heine, Lawrence A Leiter, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemiaWaleed Aldhahi, Jen Armstrong, Clara Bouche, et al.
Archives of Internal Medicine|October 27, 2004
Postprandial glucose regulation and diabetic complicationsAntonio Ceriello, Markolf Hanefeld, Lawrence Leiter, et al.
G3 (Bethesda, Md.)|June 7, 2015
CYCLoPs: A Comprehensive Database Constructed from Automated Analysis of Protein Abundance and Subcellular Localization Patterns in Saccharomyces cerevisiaeJudice L Y Koh, Yolanda T Chong, Helena Friesen, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trialsBernard Zinman, J Hans DeVries, Bruce Bode, et al.
Pageof 3